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Abstract
Background: The economic downturn exacerbates the inadequacy of resources for combating the worldwide HIV/
AIDS pandemic and amplifies the need to improve the efficiency of HIV/AIDS programs.
Methods: We used data envelopment analysis (DEA) to evaluate efficiency of national HIV/AIDS programs in
transforming funding into services and implemented a Tobit model to identify determinants of the efficiency in 68
low- and middle-income countries. We considered the change from the lowest quartile to the average value of a
variable a “notable” increase.
Results: Overall, the average efficiency in implementing HIV/AIDS programs was moderate (49.8%). Program
efficiency varied enormously among countries with means by quartile of efficiency of 13.0%, 36.4%, 54.4% and
96.5%. A country’s governance, financing mechanisms, and economic and demographic characteristics influence
the program efficiency. For example, if countries achieved a notable increase in “voice and accountability” (e.g.,
greater participation of civil society in policy making), the efficiency of their HIV/AIDS programs would increase by
40.8%. For countries in the lowest quartile of per capita gross national income (GNI), a notable increase in per
capita GNI would increase the efficiency of AIDS programs by 45.0%.
Conclusions: There may be substantial opportunity for improving the efficiency of AIDS services, by providing
more services with existing resources. Actions beyond the health sector could be important factors affecting HIV/
AIDS service delivery.
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Background
Since the beginning of the epidemic of Human Immu-
nodeficiency Virus/Acquired Immune Deficiency Syn-
drome (HIV/AIDS), almost 60 million people have been
infected with HIV and 25 million people have died of
HIV-related causes [1]. Despite the billions of dollars
spent on this disease, a gap persists between resource
needs and resources available for HIV/AIDS control and
treatment [2,3]. The economic downturn since 2008
exacerbates the inadequacy of resources for combating
the worldwide HIV/AIDS pandemic [4]. These resource
constraints amplify the need to improve the efficiency of
HIV/AIDS programs [5].
Efficiency studies conducted at the organizational level
(e.g., health centers) show a substantial variation of per-
formance (measured by program unit cost) of HIV/
AIDS interventions both within a country and across
countries [6-9]. While some of the variation is attributa-
ble to differences in the scale and the breadth of each
country’s AIDS interventions, much remains unex-
plained. Anecdotal and qualitative reports contend that
the inefficiencies of HIV/AIDS programs at a national
level are largely due to high transaction costs, repeated
investment, poor government responsiveness, and low
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factors are poorly documented with quantitative empiri-
cal data. Examining the impact of these factors would
strengthen policies and resource allocation for scaling
up HIV/AIDS services. For example, in countries where
the efficiency of HIV/AIDS services is low, priority
should be given to interventions to overcome barriers
against implementing efficient programs. On the other
hand, in countries where performance is already high,
efforts should be geared towards mobilizing more
resources.
This study uses comprehensive data released in 2008
by the Joint United Nations Programme on HIV/AIDS
(UNAIDS) [13] to quantitatively evaluate efficiency of
countries’ use of funding for HIV/AIDS, and then to
explore the impact of some social and economic deter-
minants on the efficiency.
Methods
This study followed a classical framework of economic
analysis of efficiency using a two-step process: in the
first step efficiency of national HIV/AIDS programs
were evaluated with direct inputs and outputs, and in
the second step econometric models were applied to
explain the efficiency [14]. Thus this study considers
three sets of variables from each country: (1) direct
inputs of national HIV/AIDS programs, (2) direct out-
puts of the programs, and (3) contextual factors affect-
ing the efficiency.
We used the data from UNAIDS reports on national
AIDS spending to determine the inputs for national
HIV/AIDS programs [13,15]. We standardized expendi-
tures into 2007 international dollars (I$) after adjusting
for purchasing power parity (PPP) and inflation. We
selected the number of people receiving voluntary coun-
seling and testing (VCT), the number of HIV+ pregnant
women receiving HIV/AIDS treatment for prevention of
mother-to-child transmission (PMTCT), and the num-
ber of patients receiving antiretroviral treatment (ART)
as program outputs. These three indicators were
selected as outputs because they are the standardized
services that could be compared across countries, and
they are the services for which the data are widely avail-
able and are measured more precisely. One may argue
that using these three indicators as outputs may result
in unfavorable results for those countries that focus on
prevention outside of health facilities. Based on the data
on AIDS spending released by UNAIDS in 2009 [14],
we found that VCT and PMTCT were good proxies for
AIDS prevention activities; together they were a major
component of prevention activities, accounting for
40.3% of total spending on prevention, and spending on
VCT and PMTCT was highly correlated with
expenditure on prevention with a correlation coefficient
of 0.67 (p < 0.001).
Four aspects have been highlighted by the World Bank
to improve the efficiency of funding, which include 1)
macroeconomic status, 2) social and cultural factors, 3)
infrastructure and human resources, and 4) institutional
and policy environment [4]. From the available data, we
included indicators on economic and demographic char-
acteristics, health financing mechanisms, and govern-
ance as key potential determinants of the unconditional
technical efficiency in the regression analysis. Additional
file 1 provides a detailed description of the selection of
the inputs, outputs and determinants.
Data on national HIV/AIDS expenditure and the three
types of HIV/AIDS services (VCT, PMTCT and ART)
were obtained from UNAIDS documents [13,16-19].
After compiling them, we imputed the missing values.
For countries with data available for at least two years,
we interpolated or extrapolated missing values using log
linear function. For countries with data available for one
year only, regional growth rates of the services or spend-
ing were used to impute missing values. To check the
consistency and validity of imputed data, we examined
the distribution of the imputed data and performed
separate regressions with observed and imputed data of
VCT on ART and ART on AIDS spending. We found
that 98% of imputed data points fell within the 95%
confidence interval of observed data and there were no
statistically significant differences of the slopes in the
corresponding regressions [20,21]. Data on potential
determinants were obtained from databases constructed
by the World Bank and the World Health Organization
[22,23]. The final data set covers 68 countries with 151
observations, spanning the years 2002 through 2007.
We used output-oriented data envelopment analysis
(DEA), a classic non-parametric approach to evaluating
technical efficiency [24], to estimate the efficiency of
national HIV/AIDS programs. The conventional
Charnes, Cooper, and Rhodes (CCR) model is described
further in Additional file 1[24]. As the CCR model does
not incorporate prior knowledge of the relative impor-
tance of inputs and outputs in estimating weights [25],
we used the DEA model with an assurance region (AR),
setting weight boundaries for outputs so that the relative
importance of each of the services contributing to the
efficiency is within an appropriate range; these are
described in Additional file 1.
We used DEA-solver 5.0 (Saitech Inc. New Jersey) to
estimate two sets of efficiency scores for each observa-
tion using DEA models. The first set was obtained by
running the DEA model on separate years (each country
was compared to its peers in the same year) to estimate
the efficiency of countries in implementing HIV/AIDS
Zeng et al. BMC Health Services Research 2012, 12:74
http://www.biomedcentral.com/1472-6963/12/74
Page 2 of 9programs (hereafter termed ‘separate DEA’). The second
set was calculated by pooling all countries over years
with one DEA model (each country was compared to
the best performers among the six years) (hereafter
termed ‘pooled DEA’). The results from pooled DEA
were used to examine the evolution of the performance
of national HIV/AIDS programs over time and to con-
duct the regression analysis, as described below. As
these efficiency scores were not adjusted for any factors,
we termed them unconditional efficiency scores.
After obtaining the efficiency scores from the pooled
DEA model, we constructed a random-effects Tobit
regression model with finite population adjustment as
the second stage of the efficiency analysis [14,26,27]. To
generate consistent estimates in the second stage analy-
sis, it requires the independency of inputs from contex-
tual factors used [26]. We examined the association
between HIV spending and the contextual factors used
in the Tobit model and found a low level of correlation
between them with R
2 = 0.20, which permits the use of
Tobit model in the study. The Tobit model was built on
120 observations through 2006 because the information
on health financing, one of the independent variables,
was available only through that year at the time of the
analysis (2009). We adjusted the unconditional efficiency
scores for those factors, obtaining the conditional effi-
ciency of a country’s national AIDS program. We
defined a “notable increase” as the change from the low-
est quartile to the average value of a variable. Using the
Tobit model, we derived the improvement in uncondi-
tional efficiency of an AIDS program from “notable”
increases in all key determinants. The second stage ana-
lysis was conducted with STATA 11.0 (StataCorp LP,
Texas)
Results
Of all 151 observations, 18% (27 out of 151) were on the
production frontier with efficiency scores of 100% using
the separate DEA models. The high performers included
countries that have been internationally recognized for
their successful HIV/AIDS programs such as Thailand
(2004, 2006, and 2007), Brazil (2005), and Rwanda
(2003). The concordance of our results with empirical
observations helps validate our application of DEA to
national HIV/AIDS programs and the selection of inputs
and outputs. Our highly efficient performers also
included some countries that have received less recogni-
tion, such as China (2003 and 2006), Chad (2004 and
2006), South Africa (2005, 2006, and 2007) and Para-
guay (2006 and 2007). These countries were repeatedly
ranked with 100% efficiency. Complete efficiency scores
from the DEA models for each country are provided in
Additional file 1.
The performance of countries’ HIV/AIDS programs
varied widely. The mean efficiency scores by quartile
across 151 observations over the six years were 13.0% in
quartile 1 (the worst fourth of observations), 36.4% in
quartile 2, 54.4% in quartile 3, and 96.5% in quartile 4
(the best fourth of observations). The overall average
output-oriented efficiency was 49.8% (SD = 31.2%), indi-
cating that the countries, on average, could have
doubled their outputs if they used money as efficiently
as their comparison peers in the same year. When con-
centrating on inefficient countries alone, the average
efficiency score was 38.6% (SD = 23.7%), suggesting a
possibility of increases outputs by 2.6 times if they per-
formed well.
To illustrate DEA more intuitively, Figure 1 approxi-
mates the DEA model using 2006 data, containing 45
observations, with a two-dimensional graph reduced
from an original four-dimensional process (one input
and three outputs) by standardizing the weight for
PMTCT (0.10) and VCT (0.01) relative to ART (1.0).
For the ease of interpretation we arbitrarily set the
weight for ART as 1, and computed the standardized
weights for PMTCT and VCT by averaging the relative
weights for PMTCT and VCT generated from the out-
put-oriented DEA model across the 45 observations.
The standardized weight approximately represents the
relative cost for each service. One output unit was
defined as the equivalent of providing ART for 100
patients for one year.
As expected, the results from the pooled DEA model
exhibited a wider variation of national HIV/AIDS pro-
grams. Eight observations fell on the production frontier
with efficiency scores of 100%. They were Thailand
(2007), South Africa (2007), Paraguay (2006, 2007),
China (2006), Peru (2007) and Chad (2004, 2006). It was
not surprising that the observations on the production
frontier were those from recent years because productiv-
ity has generally increased over time. Figure 2 shows
that efficiency of HIV/AIDS programs improved over
time from 13.3% before through 2004 to 47.7% in 2007.
Table 1 shows the coefficients estimated from the ran-
dom-effects Tobit model. Of all the factors on govern-
ance, “voice and accountability” and “government
effectiveness” were found to be beneficial in improving
the efficiency of HIV/AIDS programs. If the countries
achieved a notable increase in “voice and accountability”
(from -1.37 to -0.33), the efficiency would increase by
40.8%.
The positive coefficients for the two interaction terms
in the model indicate that fighting corruption would sig-
nificantly improve the efficiency of using external funds
and strengthen the impact of policy implementation on
delivering HIV/AIDS services.
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Figure 1 Reduced two-dimensional display of the performance for 45 countries in 2006. Source: Authors’ analysis of data compiled from
45 developing countries in 2006. Note: These efficiency results came from a separate DEA run for data in 2006 only.
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Figure 2 Change in efficiency of national HIV/AIDS programs in the period of 2002-2007. Source: Authors’ analysis of data compiled from
68 developing countries from 2002 to 2007. Notes: The efficiency was evaluated by the pooled DEA. Each point represents the mean efficiency
in the year(s). Due to the small sample size in years 2002 through 2004, we summarized the efficiency scores in those years.
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ture from external sources generally improved the effi-
ciency of HIV/AIDS programs. Greater external shares
had a higher impact on efficiency in a country with
lower levels of corruption. For countries with mid-level
efforts in “control of corruption” (value is 0), a notable
increase in the external share of health expenditure
(from 1.0% to 5.5%) would result in a 13.5% increase of
efficiency.
The random-effects Tobit model shows that the rela-
tionship between per capita gross national income
(GNI) and efficiency followed an inverted U-shape. Effi-
ciency rose with increasing GNI/capita up to the level of
I$ 4468. At that level, which corresponds to the income
of lower- and middle-income countries in Europe, Cen-
tral Asia, Latin America and the Caribbean [28], effi-
ciency was maximized. The income elasticity of
efficiency for a country at the median level of income (I
$2490) in the sample was 0.25. In other words, such a
country could increase its efficiency in implementing
HIV/AIDS programs by 1% with a 4% increase of its
GNI/capita. A notable increase in GNI/capita (from I$
1135 to I$ 2490) would raise the efficiency of AIDS pro-
grams by 45%.
Discussion
A 2009 analysis by UNAIDS showed that donors’ finan-
cial commitments to HIV/AIDS, while impressive, cover
only 54% of the resources needed to meet the goal of
universal access [2]. At the AIDS 2010 conference, ana-
lysts warned that weak economic conditions jeopardized
continued funding for HIV/AIDS. Most analyses con-
clude that improving the efficiency of existing invest-
ments would contribute to resolving this challenge.
We found that the unconditional efficiency of national
HIV/AIDS programs was about 50%. This result echoes
the previously reported wide variation of efficiency in
delivering selected HIV/AIDS services [6]. We note,
however, that i) these unconditional efficiency scores do
not account for the countries’ characteristics (e.g., preva-
lence of HIV), and thus the scores may not perfectly
match experts’ perception; ii) the non-parametric DEA
does not account for measurement errors, although con-
sidered in the second stage of the DEA model. Poor
countries are likely to have lower accuracy in term of
measuring both inputs and outputs; and iii) for coun-
tries that achieved 100% efficiency, the result does not
mean that their efficiency cannot be improved in the
future; it simply says that at a given level of expenditure
on AIDS no other countries produce more outputs than
they do. Their performance could be improved through
enhanced procurement, better management of human
resources, and other advances of management and tech-
nical interventions.
If all the countries studied were completely efficient,
taking all 151 observationsa saw h o l e ,t h e i ro u t p u t
levels would have increased by 112% for VCT, 65% for
PMTCT, and 85% for ARV treatment (see Table A4 in
Additional file 1). The 27 efficient observations would,
at least, need to maintain service outputs at the histori-
cal level of expenditures. For the 124 inefficient observa-
tions, however, the volume of services would need to
increase by 198% for VCT, 128% for PMTCT, and 155%
for ARV treatment at current spending levels. These
projected increases might raise VCT services in some
c o u n t r i e sb e y o n dt h e i rn e e d sa se s t i m a t e db yU N A I D S .
To avoid that excess, countries could alternate PMTCT
and ARV treatment services instead if funding were
Table 1 Determinants of efficiency of national HIV/AIDS programs
Determinant (independent variable) Coefficient Standard Error
Voice and accountability (VA)** 0.392 0.208
Government effectiveness (GE) 0.500 0.488
Rule of law (RL) -0.333 0.475
Control of corruption (CC) -0.323 0.428
Government commitment to health* 0.031 0.021
External source as percentage of total health expenditure ** 0.030 0.014
Government source as percentage of total health expenditure * -0.014 0.008
CC × RL ** 0.602 0.312
CC × external share of health spending* 0.022 0.012
Log(GNI per capita)* 3.485 1.992
Square of log(GNI per capita)* -0.207 0.128
Log(adult population)* 0.147 0.091
HIV/AIDS prevalence (in percentage points)** 0.052 0.021
Source: Authors’ analysis of determinants of the efficiency of national HIV/AIDS programs, based on the efficiency scores generated from the pooled DEA model.
Notation: * p < 0.05, ** p < 0.01. Notes: The dependent variable is natural logarithm of efficiency scores from output-oriented DEA over years; coefficients for
dummy variables on years 2003-2007 and the constant are suppressed for brevity; log refers to natural log; the total number of observations is 120. GNI denotes
gross national income. The variance of the random error is estimated at 0.111. Additional file 1 (Table A5) provides the full model specification.
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substitute regular VCT for an intensive level of VCT
with better quality to enhance the effectiveness of VCT
on averting risk populations from HIV infection [14].
The major contribution of this study is that it provides
further insights into global resource allocation for HIV/
AIDS. Findings indicate not only adjustments to total
donor funding for a country, but also constructive
changes in country infrastructure. To expand the cover-
age of HIV/AIDS services, countries could seek to
obtain more resources, improve efficiency, or pursue a
combined approach. Countries such as Thailand, China,
and Brazil which have been efficient in providing ser-
vices would need to increase financial support in order
to scale up HIV/AIDS services. For countries with lower
efficiency but a high HIV/AIDS burden, a combined
approach is needed to simultaneously strengthen the
capacity of public systems to increase efficiency for the
long-term sustainability of AIDS control, and improve
resource allocation to address immediate needs. In addi-
tion, by enhancing the efficiency with which HIV/AIDS
funding is used, countries with low or moderate HIV/
AIDS burden could reduce their HIV/AIDS spending
and reallocate their limited resources to other diseases
[29]. Table 2 categorizes the countries in our 2006 ana-
lysis based on: 1) the efficiency of their HIV/AIDS pro-
gram and 2) the type of HIV/AIDS epidemic.
Improving governance of a country is a long-term
process but it brings sustained and substantial benefits.
In our analysis, high transparency, accountability and
involvement of local communities in decision-making
are major contributors to improved efficiency of HIV/
AIDS programs. The results are consistent with the par-
ticipatory involvement of civil society in the control of
HIV/AIDS advocated by UNAIDS and WHO [30].
Strengthening civil society through voice and account-
ability allows civil society to be more active in engaging
in making policy in favor of vulnerable populations (e.g.
t h ep o o ra n dp e o p l ew i t hH I V / A I D S ) .I nm a n y
circumstances, civil society is directly involved in service
delivery (e.g. medical treatment, HIV/AIDS testing, and
disaster relief) to needed populations to complement
governments’ efforts, ensuring the services meet the
needs of target populations [31,32]. Please note that our
study does not measure “voice and accountability” speci-
fic for AIDS. The close relationship between “voice and
accountability” in a country and HIV/AIDS service
delivery indicates that the improved HIV/AIDS service
provision are probably due to active involvement of
HIV/AIDS civil society where “voice and accountability”
for AIDS are high too. For the over 50% of all observa-
tions with a negative score on “voice and accountabil-
ity,” there is great potential for improving HIV/AIDS
service delivery.
The inverted U-shape relationship between GNI/capita
and efficiency in the random-effects Tobit model sug-
gests a positive association between GNI/capita and
AIDS program efficiency among countries with GNI/
capita < I$ 4468. This association is probably due to
better general infrastructure (e.g., road and transporta-
tion) and higher health capacities (e.g., personnel, infor-
mation system, coordination, and management) among
countries with higher per capita income, which increases
both the demand for and the supply of AIDS services
and thus contributes to the high volume of services
being provided at lower costs (economies of scale).
However, the association between GNI/capita and the
efficiency is opposite among countries with GNI/capita
> I$ 4468 where, usually, health infrastructure has been
in place. Often wages for health personnel and the
expected quality of services is higher among wealthier
countries [33,34]. These factors would result in a higher
unit cost for HIV/AIDS service provision in those
countries.
Concerns have been raised as to how best to target
the limited resources to poor countries with greater
n e e d sf o rH I V / A I D S[ 3 2 ] .A sasupplemental analysis,
we examined the association between GNI/capita with
Table 2 A two-dimensional categorization of 45 countries in 2006
Service scale-
up
mechanism
Type of HIV/AIDS epidemic
Low or concentrated (25 countries) Generalized (20countries)
Resource
oriented
(22 countries)
Brazil, China, Jamaica, Mali, Mauritius, Paraguay, Peru, Thailand, Uruguay Botswana, Cameroon, Chad, Congo Dem. Rep., Cote
d’Ivoire, Lesotho, Mozambique, Rwanda, South Africa,
Swaziland, Togo, Uganda, Zambia
Efficiency
oriented
(23 countries)
Argentina, Belize, Cambodia, Colombia, El Salvador, Guatemala,
Honduras, Indonesia, Iran, Lao RDR, Latvia, Nepal, Niger, Romania,
Senegal, Vietnam
Angola, Benin, Burkina Faso, Central African Republic,
Eritrea, Haiti, Tanzania
Source: Authors’ analysis of data compiled from 45 developing countries in 2006
Notes: The HIV/AIDS epidemics are classified according to WHO.
a We categorized countries according to the efficiency of their national AIDS programs using a
separate DEA. for data in 2006 only. Countries above the median efficiency were termed “resource oriented” while those at or below the median were termed
“efficiency oriented”
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the random-effects Tobit model that takes a country-
specific effect into consideration, the pooled Tobit
model excludes it because the country-specific term
may reflect unobserved implementation capacity of
HIV/AIDS programs in that country. We found there
was no relationship between the efficiency of HIV/AIDS
programs and GNI/capita (t = 0.30 for log[GNI per
capita] and t = -0.11for square of log[GNI per capita],
both p > 0.05), which suggests that low-income coun-
tries could be at least as efficient as wealthier countries,
and that the poor and wealthier countries have similar
levels of performance in implementing HIV/AIDS pro-
grams as long as they have comparable policy and insti-
tutional development [35]. This finding rebuts the
argument that donors should reduce funding for HIV/
AIDS services in low-income countries. International
donors instead need to continue their efforts in poor
countries, helping them shape health care systems and
improve their governance to address HIV/AIDS. It is
beneficial, not just from an ethical perspective, to boost
efforts to combat HIV/AIDS in the poorest countries.
From a technical perspective, investing in low-income
countries does not reduce the pace of the global battle
with HIV/AIDS.
The main results of this study measure the uncondi-
tional efficiency of a country overall in addressing HIV/
AIDS, but do not necessarily reflect the performance of
the country’s health care system specifically, which is
often operated under the constraints of a country’sg e n -
eral contextual factor (such as the type of epidemics and
governance).
Critics may question the use of a single production
frontier to evaluate all the countries in all years, since
countries face different types of epidemics and different
political constraints. For example, some countries may
perform well because of the favorable environment,
such as better governance, while other countries may
deliver a mediocre amount of HIV/AIDS services under
a harsh environment. When evaluating the efficiency of
health care systems in addressing HIV/AIDS, we have to
take into consideration countries’ environmental factors
beyond health sectors by adjusting the efficiency of
HIV/AIDS programs for them. The adjustment is analo-
gous to generating multiple production frontiers for the
countries to be evaluated. We used the coefficients in
Table 1 to estimate the efficiency of the health care sys-
tem at the mean level of countries’ factors. We included
all the independent variables in the regression except
the three variables on health expenditure that fall within
the health care system. For a country with favorable
contextual factors, the adjustment lowered the estimated
efficiency, since some reasons for success fell outside of
the health system. Conversely, the efficiency was
adjusted up if a country has a harsher policy environ-
ment. For example, the efficiency of Brazil (2006)
increased to 100% after the adjustment. Country-level
results are available from the authors.
As evidence for the validating the use of DEA to
assess the efficiency of national HIV/AIDS programs, we
f o u n dt h a t1 )s o m ec o u n t r i e s( e . g . ,B r a z i l ,R w a n d a ,a n d
Thailand), whose performance is widely respected,
received excellent unconditional scores from our analy-
sis; more countries emerge as conditionally efficient
after the adjustment for the epidemics and macroeco-
nomic factors, and 2) most coefficients from the Tobit
regression bear the expected signs.
Our findings are subject to several caveats, however,
and should be interpreted with caution. First, the selec-
tion of inputs and outputs was limited by data availabil-
ity. Due to this constraint, we could not include human
resources as an input and some key services, such as
support to orphans and vulnerable children, as outputs
in the model. Furthermore, as all three outputs (VCT,
PMTCT and ARV) are services in health facilities [36],
the unconditional efficiency scores favor countries
focusing on medical activities. South Africa’sh i g h
unconditional efficiency score is an example. Further
refinement of efficiency scores could be examined using
the country’s HIV/AIDS prevalence and results of Tobit
regressions. Second, the assumption that the outputs for
the year result entirely from inputs in the same year in
the DEA model is not completely valid in HIV/AIDS
programs. Lags between inputs and outputs exceeding
one year exist in many international assistance programs
[37]. Third, the quality of the outputs is not factored
into the analysis due to the absence of systematic data.
More limited studies have shown variations in the effec-
tiveness of a given intervention across countries [21,37],
indicating the value of monitoring and evaluating the
quality of services in a country’s HIV/AIDS program. If
a trade-off between quantity and quality exists, we
should regard the coefficients in the model as upper
bound of the estimates given the positive association
between governance and the quality. Fourth, the coun-
try-level data may have a serious measurement problem.
It is likely that measurement errors are not independent
from the contextual factors (e.g. countries with poor
g o v e r n a n c ea r em o r el i k e l yt oh a v em e a s u r e m e n t
errors). The presence of measurement errors could bias
the estimates for the contextual factors. Given these lim-
itations, we note that our results are indicative rather
than conclusive.
As this study concentrated on the technical efficiency
of service delivery, we acknowledge that the efficiency of
a country’s HIV/AIDS program must be interpreted in a
broader context of that country, because efficiency is
not the only one domain in evaluating a program. Other
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nomic, political and equity issues.
Two future studies would merit special attention.
First, a similar study could be expanded to include addi-
tional indicators, which might focus specifically on char-
acteristics of the health system rather than the overall
society. The current study has shown the feasibility and
value of that approach. Second, as efficiency can sub-
stantially relieve the financial pressure for scaling up
HIV/AIDS services, it would be important to incorpo-
rate it into future projections of resource needs for
HIV/AIDS.
Conclusions
Although efficiency scores of national HIV/AIDS pro-
grams are only indicative, given the limitations of the
study, our findings suggest that there may be substantial
room for improving HIV/AIDS services at the country
level with the existing resources. Improving the effi-
ciency of HIV/AIDS services requires actions not only
within the health sector, but also in the broader context,
such as governance, to ensure that HIV/AIDS funding
materializes into services that are targeted to and benefit
the population in need. Given the limited resources
available for HIV/AIDS services, it is critical to under-
stand countries’ performance in delivering HIV/AIDS
services to inform strategies to scale up HIV/AIDS ser-
vices and to help allocate the available funding wisely to
combat HIV/AIDS.
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